Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

56.94 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
MedTech Round Up: Update On Products By Biomerica, 908 Devices, Ekso Bionics, Hologic
Biomerica Inc (NASDAQ: BMRA) has announced that its new COVID-19 Antigen Rapid Test can now be performed with a simple, less invasive nasal swab. The test is... 
Via Benzinga
Exposures COVID-19
Hologic and Partners Launch Project Health Equality to Help Transform the Care Women of Color Receive in the Health Care System
From Hologic, Inc.
Via Business Wire
Medicare Insurance Coverage for Breast Cancer Index™ Test Expanded to Include Node-Positive Breast Cancer
From Hologic, Inc.
Via Business Wire
Will the End of the Pandemic Bring an End to This Healthcare Company?
Getting beyond COVID-19 starts with going back to the base business. 
Via The Motley Fool
Topics Earnings
Exposures COVID-19 Financial
Why Vaccines Might Not Spell Downturn For Covid Testing Firms
Investors should hold off permanently rebranding diagnostics stocks as coronavirus stocks, experts say. There's a chance their future could be much bigger. 
Via Investor's Business Daily
Exposures COVID-19
Health Crisis Leads to Surge in Medical Technology Innovation
Via FinancialNewsMedia
Liver Cancer Diagnostics Market Demand 2021 Competitive Landscape, Research Methodology, Business Opportunities, Statistics and Industry Analysis Report by 2028
This is another factor projected to boost market growth over the forecast period. 
Via SBWire
Topics Supply Chain
Exposures Supply Chain
Tuberculosis Diagnostics Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027 : Reports and Data
Increase in the incidence of tuberculosis in developing countries and rise in awareness about the disease are driving growth of the tuberculosis diagnostics market. 
Via SBWire
Topics Death Economy
Exposures COVID-19 Death Economy
Hologic to Webcast Presentations at Upcoming Virtual Investor Conferences
From Hologic, Inc.
Via Business Wire
HLA Typing for Transplant Market Size USD 1,206.02 Million by 2028 Says a New Research Report by Reports and Data
HLA matching boosts development of new healthy blood cells and reduces the chances of graft-versus-host disease. 
Via SBWire
65 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs. Takung Art Co., Ltd. (... 
Via Benzinga
Clinical Microbiology Market worth $5.3 billion by 2025 | Growth Factors, Top Players and Competitive Regional Growth Analysis
Via AB Newswire
Topics Supply Chain
Exposures COVID-19 Supply Chain
54 Stocks Moving In Thursday's Mid-Day Session
Gainers Willamette Valley Vineyards, Inc. (NASDAQ: WVVI) climbed 40.5% to $14.39. Dolphin Entertainment, Inc. (NASDAQ: DLPN) shares gained 23.1% to $14.14. Dolphin Entertainment... 
Via Benzinga
Return On Capital Employed Overview: Hologic
Hologic (NASDAQ:HOLX) posted Q2 earnings of $782.10 million, an increase from Q1 of 12.13%. Sales dropped to $1.54 billion, a 4.47% decrease between quarters. In Q1, Hologic... 
Via Benzinga
Bright Pink Honors ChangeMakers Taking Action to Support Health Equity
ChangeMakers Debuts Online May 25 Supporting Women’s Health by Ensuring Information and Access for All. Register here https://brightpink.org/change/ 
Via EIN Presswire
Hologic Shares Drop On Q2 Earnings Miss; Q3 Guidance Trail Consensus
Hologic Inc (NASDAQ: HOLX) posted second-quarter results that trailed the consensus forecast; however, the company tried to provide some cushion with a better... 
Via Benzinga
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) shares increased by 42.2% to $9.4 during Thursday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Gainers Galera Therapeutics, Inc. (NASDAQ: GRTX) rose 39.6% to $9.23 in pre-market trading after the company disclosed updated data from its randomized, multicenter, placebo-... 
Via Benzinga
Hologic Inc (HOLX) Q2 2021 Earnings Call Transcript
HOLX earnings call for the period ending March 27, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
13 Stocks Moving In Wednesday's After-Hours Session
Gainers Facebook (NASDAQ: FB) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also reported average daily... 
Via Benzinga
Recap: Hologic Q2 Earnings
Shares of Hologic (NASDAQ:HOLX) fell in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 354.39% year over year to $2.59... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Galera Therapeutics (NASDAQ:GRTX) stock moved upwards by 23.75% to $8.18 during Wednesday's after-market session. Today's trading volume for this security ended up... 
Via Benzinga
Hologic Announces Financial Results for Second Quarter of Fiscal 2021
From Hologic, Inc. 
Via Business Wire
Influenza Diagnostics Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2027
The ongoing COVID-19 pandemic and the worldwide reaction to it have compelled companies to radically rethink their strategies and the way they operate. 
Via SBWire
Topics Economy
Exposures COVID-19 Economy
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc... 
Via Benzinga
Exposures Product Safety
Molecular Diagnostics Market Worth $31.8 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The global molecular diagnostics market size is projected to reach $31.8 billion by 2026. Oncology testing market report provides crucial industry insights that will help your business grow. 
Via SBWire
Exposures COVID-19
Computer Aided Diagnostics (CAD) Market High Demand, Business Scenario, Size, Share, Growth, Insights, Industry Analysis, Trends and Forecasts Report 2028
The study methodologies used to examine the Computer Aided Diagnostics (CAD) market for the forecast period, 2020 - 2028 further classifies the industry by type, geography, end-use and end-user to add... 
Via SBWire
Exposures COVID-19
3 MedTech Subsectors Poised to Perform Impressively in Q121
Here are three MedTech subindustries, which have been performing steadily through the pandemic year and are likely to have held ground in the soon-to-be-reported quarter. 
Via Talk Markets
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.